Biological PsychiatryGeneticsPeer-reviewed journal article
Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders
Gabriëlla A.M. BloklandiD, Jakob GroveiD, Chia‐Yen CheniD, Chris J. CotsapasiD, Stuart A. TobetiD, Robert J. HandaiD, Stephan RipkeiD, Benjamin M. NealeiD, Aiden Corvin, James WaltersiD, Kai-How Farh, Peter HolmansiD, Phil LeeiD, Brendan K Bulik-SullivaniD, David Andrew CollieriD, Hailiang HuangiD, Tune H. PersiD, Ingrid AgartziD, Esben AgerboiD, Margot AlbusiD, Madeline Alexander, Farooq Amin M. D, Silviu‐Alin BacanuiD, Martin BegemanniD, Richard A. Belliveau, , Joel N. HirschhorniD
- Citations
- 135
- FWCI
- 8.49
- Field percentile
- top 1%
Abstract
BACKGROUNDSex differences in incidence and/or presentation of schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for shared genetic risk and sex differences in brain abnormalities across disorders suggest possible shared sex-dependent genetic risk. METHODSWe conducted the largest to date genome-wide genotype-by-sex (GxS) interaction of risk for these disorders, using 85,735 cases (33,403 SCZ, 19,924 BIP, 32,408 MDD) and 109,946 controls from the Psychiatric Genomics Consortium (PGC) and iPSYCH. RESULTSAcross disorders, genome-wide significant SNP-by-sex interaction was detected for a locus encompassing NKAIN2 (rs117780815; p=3.2x10-8), that interacts with sodium/potassium-transporting ATPase enzymes implicating neuronal excitability. Three additional loci showed evidence (p<1x10-6) for cross-disorder GxS interaction (rs7302529, p=1.6x10-7; rs73033497, p=8.8x10-7; rs7914279, p=6.4x10-7) implicating various functions. Gene-based analyses identified GxS interaction across disorders (p=8.97x10-7) with transcriptional inhibitor SLTM. Most significant in SCZ was a MOCOS gene locus (rs11665282; p=1.5x10-7), implicating vascular endothelial cells. Secondary analysis of the PGC-SCZ dataset detected an interaction (rs13265509; p=1.1x10-7) in a locus containing IDO2, a kynurenine pathway enzyme with immunoregulatory functions implicated in SCZ, BIP, and MDD. Pathway enrichment analysis detected significant GxS of genes regulating vascular endothelial growth factor (VEGF) receptor signaling in MDD (pFDR<0.05). CONCLUSIONSIn the largest genome-wide GxS analysis of mood and psychotic disorders to date, there was substantial genetic overlap between the sexes. However, significant sex-dependent effects were enriched for genes related to neuronal development, immune and vascular functions across and within SCZ, BIP, and MDD at the variant, gene, and pathway enrichment levels.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptional and genetic sex differences for schizophrenia across the dorsolateral prefrontal cortex, hippocampus, and caudate nucleus
Kynon JM Benjamin, Ria Arora, … Jennifer A. Erwin·medRxiv·Sep 30, 2022
- Elucidating the Joint Genetic Architecture of Mood Disorder and Schizophrenia
Max Lam, Meiling Thompson, … Hailiang Huang·medRxiv·Sep 14, 2020
- Identifying and Characterising Common Genetic Differences in Schizophrenia and Bipolar Disorder
Isabella R. Willcocks, Alexander L. Richards, … James Walters·medRxiv·Jul 19, 2026
- Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample
Yousef Khan, Christal N. Davis, … Rachel L. Kember·medRxiv·May 9, 2024
- Sex differences in the human brain transcriptome of cases with schizophrenia
Gabriel E. Hoffman, Yixuan Ma, … Panos Roussos·Biological PsychiatryPeer-reviewed·Jan 1, 2022
- Conditional GWAS analysis identifies putative disorder-specific SNPs for psychiatric disorders
Enda M. Byrne, Zhihong Zhu, … Naomi R. Wray·bioRxiv·Mar 31, 2019